The role of polymerase chain reaction in the laboratory diagnosis of infectious mononucleosis in children
https://doi.org/10.66825/2949-4664-apps-4-1-66-71
Abstract
Infectious mononucleosis (IM), caused by the Epstein-Barr virus (EBV), remains one of the most pressing problems in pediatric infectology. Despite a relatively favorable course in immunocompetent children, this infection requires accurate laboratory verification for differential diagnosis from acute leukemia, streptococcal sore throat, and other diseases. This review critically analyzes current methods for laboratory diagnostics of IM, with a particular emphasis on polymerase chain reaction (PCR) in its various modifications. The principles of molecular diagnostics, optimal assay matrices, interpretation of quantitative viral load indicators, and age-related characteristics of this method’s use in pediatric practice are discussed. Data on the comparative effectiveness of PCR, serological tests, and direct virus detection methods are presented. Promising approaches, including digital PCR and next-generation sequencing (NGS), in the diagnosis of EBV-associated diseases are discussed. The results of a retrospective analysis of 309 suspected IM cases in children are presented, demonstrating the high diagnostic value of the PCR method. The review is based on an analysis of current international guidelines and meta-analyses of recent years.
About the Authors
E. V. PavlenkoRussian Federation
Ekaterina V. Pavlenko, 6th-year student
85 Pobedy st., Belgorod, 308015
Competing Interests:
The authors declare no conflict of interest.
K. A. Bocharova
Russian Federation
Ksenia A. Bocharova, Dr. Sci. (Med.), Head of the Department of Microbiology and Virology with the Course of Clinical Immunology
85 Pobedy st., Belgorod, 308015
Competing Interests:
The authors declare no conflict of interest.
References
1. Kaye K. M. Infectious Mononucleosis. MSD Manual Professional Edition. Merck & Co., Inc., 2024. URL: https://www.msdmanuals.com/professional/ infectious-diseases/herpesviruses/infectiousmononucleosis (accessed March 16, 2026).
2. Johannsen E.C., Schooley R.T., Kaye K.M. Epstein – Barr virus (infectious mononucleosis). In: Bennett J.E., Dolin R., Blaser M.J., eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Elsevier; 2020: chap 139.
3. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964; 1 (7335): 702–703. DOI: 10.1016/s0140-6736(64)91524-7.
4. Al-Qurashi A.M., Al-Qahtani A.A., Al-Qarni S.S., et al. Molecular epidemiology and clinical patterns of Epstein– Barr virus infection in Southwestern Saudi Arabia: a 2020–2023 retrospective study. BMC Infect. Dis. 2025; 25: 11407. DOI: 10.1186/s12879-025-11407-2.
5. Centers for Disease Control and Prevention (CDC). Laboratory Testing for Epstein–Barr Virus (EBV). URL: https://www.cdc.gov/epstein-barr/php/laboratories/index.html (accessed 15.01.2025).
6. Shannon-Lowe C., Rickinson A. The global landscape of EBV-associated tumors. Front. Oncol. 2019; 9: 713. DOI: 10.3389/fonc.2019.00713.
7. Mikhailchenko V.A., Volobueva S. Yu., Pavlenko E. V., et al. The Role of Polymerase Chain Reaction in the Laboratory Diagnosis of Infectious Mononucleosis Caused by the Epstein-Barr Virus. Laboratory Diagnostics Eastern Europe. 2026; 15(1): 299–300 – Electronic Supplement (Materials of the IV Russian Congress with International Participation on Medical Microbiology and Infectology, Moscow, February 26– 27, 2026) (in Rus.).
8. Mrzljak A., Novak A., Kolic K., et al. Clinical Features and Laboratory Findings of Hospitalized Children with Infectious Mononucleosis Caused by Epstein – Barr Virus from Croatia. Pathogens. 2025; 14 (4): 374. DOI: 10.3390/pathogens14040374
9. Li Y., Li X., Zhang Y., et al. Active EBV infection in children: associations between DNA load, infection status, immune status, and disease severity. BMC Pediatr. 2025; 25: 98. DOI: 10.1186/s12887-025-04642-3.
10. Yu H., Robertson E.S. Epstein-Barr Virus History and Pathogenesis. Viruses. 2023 Mar 9; 15 (3): 714. DOI: 10.3390/v15030714.
11. Corrales I., Giménez E., Navarro D. Evaluation of the Architect Epstein–Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method. Clin Vaccine Immunol. 2014 May; 21(5): 684–8. DOI: 10.1128/CVI.00104-14.
12. Hatton O.L., Harris-Arnold A., Schaffert S., et al. The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease. Immunol Res. 2014 May; 58 (2–3): 268-76. DOI: 10.1007/s12026-014-8496-1.
13. ARUP Laboratories. Epstein – Barr Virus – EBV | Choose the Right Test. URL: https://arupconsult.com/content/epstein-barr-virus (accessed 15.01.2025).
14. Infectious Disease Advisor. Epstein – Barr Virus | Diagnosis & Disease Information. URL: https://www.infectiousdiseaseadvisor.com/ddi/epstein-barr-virus/ (accessed 15.01.2025).
15. Rezk E., Nofal Y.H., Hamzeh A., et al. Steroids for symptom control in infectious mononucleosis. Cochrane Database Syst. Rev. 2015; (11): CD004402. DOI: 10.1002/14651858.CD004402.pub3
Review
For citations:
Pavlenko E.V., Bocharova K.A. The role of polymerase chain reaction in the laboratory diagnosis of infectious mononucleosis in children. Archives of Pediatrics and Pediatric Surgery. 2026;4(1):66-71. (In Russ.) https://doi.org/10.66825/2949-4664-apps-4-1-66-71
JATS XML














